Oncolytics Biotech (ONCY) Accumulated Expenses (2024 - 2026)
Oncolytics Biotech (ONCY) posted Accumulated Expenses of $1.68 million for Q2 2026.
Powered by 
Analysis
Oncolytics Biotech (ONCY) Accumulated Expenses (2024 - 2026) Analysis & Trends
At the end of FY2025, Oncolytics Biotech's Accumulated Expenses came in at $2.33 million, down 9.6% from FY2024.
- In prior years, Oncolytics Biotech's Accumulated Expenses was $2.57 million in FY2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Oncolytics Biotech | 62.32 Mn | 33.44 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.68 Mn |
| Dec 31, 2025 | 2.33 Mn |
| Dec 31, 2024 | 2.57 Mn |
API Access
Oncolytics Biotech Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ONCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "ONCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ONCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();